Godlike Productions - Reply to Thread

Users Online Now: 2,198 (Who's On?)	Visitors Today: 2,124,749
Pageviews Today: 2,951,898	Threads Today: 697	Posts Today: 13,985
10:19 PM

REPLY TO THREAD

Subject NEW: National Institutes of Health has halted a large clinical trial of hydroxychloroquine after finding no benefit to coronavirus patients

User Name

Font color: Font:

In accordance with industry accepted best practices we ask that users limit their copy / paste of copyrighted material to the relevant portions of the article you wish to discuss and no more than 50% of the source material, provide a link back to the original article and provide your original comments / criticism in your post with the article.

Original Message The National Institutes of Health has halted its clinical trial of the anti-malaria drug hydroxychloroquine after finding that the treatment provides no benefit to COVID-19 patients.

The decision to end the trial comes after the Food and Drug Administration revoked emergency use of the drug on Monday and the World Health Organization dropped the drug from its global study on Wednesday.

“A data and safety monitoring board met late Friday and determined that while there was no harm, the study drug was very unlikely to be beneficial to hospitalized patients with COVID-19,” the NIH said in a statement on Saturday.

The FDA has also determined the drug is “unlikely to be effective in treating COVID-19” and warned of side effects including serious heart rhythm problems.

Hydroxychloroquine is used to treat malaria and rheumatoid conditions like arthritis. The drug generated excitement earlier in the year after a few small studies suggested it could be beneficial for treating coronavirus.

However, larger studies showed the drug was not helpful and caused heart issues in some patients, and a study in the New England Journal of Medicine found hydroxychloroquine didn’t work any better than a placebo in preventing coronavirus infections.

[link to www.cnbc.com (secure)]

Pictures (click to insert)





\| Next Page >>